HuGE Literature Finder
Records
1
-
15
| Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender. Aging 2022 3 14 (5): 2148-2173. Lee Joon Yan Selene, Ng Jing Han, Saffari Seyed Ehsan, Tan Eng-Ki |
| SNPs within microRNA binding sites and the prognosis of breast cancer. Aging 2021 Feb 13 (5): 7465-7480. Zhang Liwen, Han Lu, Huang Yubei, Feng Ziwei, Wang Xin, Li Haixin, Song Fangfang, Liu Luyang, Li Junxian, Zheng Hong, Wang Peishan, Song Fengju, Chen Kex |
| LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma. Cancer cell international 2021 7 21 (1): 343. Yang Chunxiu, Pang Jingjing, Xu Jian, Pan He, Li Yueying, Zhang Huainian, Liu Huan, Xiao Shu-Yu |
| Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors. Human molecular genetics 2021 5 30 (18): 1750-1761. Cheung Mitchell, Kadariya Yuwaraj, Sementino Eleonora, Hall Michael J, Cozzi Ilaria, Ascoli Valeria, Ohar Jill A, Testa Joseph |
| Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas Associated with High Mutation Burden. The American journal of pathology 2020 Sep . Parrilla Castellar Edgardo R, Plichta Jennifer K, Davis Richard, Gonzalez-Hunt Claudia, Sanders Laurie |
| Comprehensive Genomic Analysis Reveals the Prognostic Role of LRRK2 Copy-Number Variations in Human Malignancies. Genes 2020 7 11 (8): . Lopez Gianluca, Lazzeri Giulia, Rappa Alessandra, Isimbaldi Giuseppe, Cribiù Fulvia Milena, Guerini-Rocco Elena, Ferrero Stefano, Vaira Valentina, Di Fonzo Aless |
| Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls. Movement disorders : official journal of the Movement Disorder Society 2019 Jul . Agalliu Ilir, Ortega Roberto A, Luciano Marta San, Mirelman Anat, Pont-Sunyer Claustre, Brockmann Kathrin, Vilas Dolores, Tolosa Eduardo, Berg Daniela, Warø Bjørg, Glickman Amanda, Raymond Deborah, Inzelberg Rivka, Ruiz-Martinez Javier, Mondragon Elisabet, Friedman Eitan, Hassin-Baer Sharon, Alcalay Roy N, Mejia-Santana Helen, Aasly Jan, Foroud Tatiana, Marder Karen, Giladi Nir, Bressman Susan, Saunders-Pullman Rach |
| The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates. Journal of cellular physiology 2019 Jul 234 (7): 10918-10925. Meng Fanlu, Zhang Linlin, Ren Yaoyao, Ma Qi |
| Novel Cell-Based Assay for Identification of LRRK2 Inhibitors Using Its Aberrant Regulation of a Pluripotency Gene. SLAS discovery : advancing life sciences R & D 2019 8 25 (1): 104-112. Ramonet David, Dietz Gunnar P |
| Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease. Brain and behavior 2018 Jan 8 (1): e00858. Warø Bjørg Johanne, Aasly Jan |
| Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology. Brain research 2018 7 1701 75-84. Mamais Adamantios, Manzoni Claudia, Nazish Iqra, Arber Charles, Sonustun Berkiye, Wray Selina, Warner Thomas T, Cookson Mark R, Lewis Patrick A, Bandopadhyay Ri |
| Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. JAMA neurology 2015 Jan 72 (1): 58-65. Agalliu Ilir, San Luciano Marta, Mirelman Anat, Giladi Nir, Waro Bjorg, Aasly Jan, Inzelberg Rivka, Hassin-Baer Sharon, Friedman Eitan, Ruiz-Martinez Javier, Marti-Masso Jose Felix, Orr-Urtreger Avi, Bressman Susan, Saunders-Pullman Rach |
| Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2. Movement disorders : official journal of the Movement Disorder Society 2014 May 29 (6): 750-5. Ruiz-Martínez Javier, de la Riva Patricia, Rodríguez-Oroz Maria C, Mondragón Rezola Elisabet, Bergareche Alberto, Gorostidi Ana, Gago Belen, Estanga Ainara, Larrañaga Nerea, Sarasqueta Cristina, López de Munain Adolfo, Martí Massó José |
| The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology 2012 Feb . Inzelberg R, Cohen OS, Aharon-Peretz J, Schlesinger I, Gershoni-Baruch R, Djaldetti R, Nitsan Z, Ephraty L, Tunkel O, Kozlova E, Inzelberg L, Kaplan N, Fixler Mehr T, Mory A, Dagan E, Schechtman E, Friedman E, Hassin-Baer S |
| LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease. Movement disorders : official journal of the Movement Disorder Society 2010 Nov 25 (15): 2536-41. Saunders-Pullman Rachel, Barrett Matthew J, Stanley Kaili M, Luciano Marta San, Shanker Vicki, Severt Lawrence, Hunt Ann, Raymond Deborah, Ozelius Laurie J, Bressman Susan |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: